Chorionic Gonadotropin

• 

  Subject Areas on Research

  • 5-day methotrexate for women with metastatic gestational trophoblastic disease. 
  • A review of surgical treatment of undescended testes with emphasis on anatomical position. 
  • A serum-free defined culture system which maintains follicle-stimulating hormone responsiveness and differentiation of porcine granulosa cells. 
  • Altered cyclic AMP-dependent human chorionic gonadotropin production in cultured human placental trophoblasts exposed to ethanol. 
  • Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements. 
  • Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. 
  • Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients. 
  • Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-1975. 
  • Changes in (125I) labeled human chorionic gonadotropin (hCG) binding to porcine granulosa cells during follicle development and cell culture. 
  • Combined serum and ultrasound screening for detection of fetal aneuploidy. 
  • Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists surveys: alpha-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin, and prostate-specific antigen. 
  • Contemporary approaches to prenatal diagnosis. 
  • Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery. 
  • Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers. 
  • Developmental coordination of luteinizing hormone/human chorionic gonadotropin (hCG) receptors and acute hCG responsiveness in cultured and freshly harvested porcine granulosa cells. 
  • Differential effect of cyclic adenosine monophosphate on the secretion of human placental lactogen and human chorionic gonadotropin. 
  • Early pregnancy interruption with two 15-ME-PGF2a suppositories. 
  • Effects of bovine luteinizing hormone and human chorionic gonadotrophin on the bovine corpus luteum in vivo. 
  • Effects of prenatal treatment with antiandrogens on luteinizing hormone secretion and sex steroid concentrations in adult spotted hyenas, Crocuta crocuta. 
  • Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. 
  • Evaluation of prognostic factors and staging in gestational trophoblastic tumor. 
  • Evidence-based pregnancy testing in clinical trials: Recommendations from a multi-stakeholder development process. 
  • Expression and production of interleukin-10 by human trophoblast: relationship to pregnancy immunotolerance. 
  • First-trimester human chorionic villi express both immunoregulatory and inflammatory cytokines: a role for interleukin-10 in regulating the cytokine network of pregnancy. 
  • Follicle-stimulating hormone-mediated induction of functional luteinizing hormone/human chorionic gonadotropin receptors during monolayer culture of porcine granulosa cells. 
  • Gestational trophoblastic disease metastatic to the central nervous system. 
  • Growth factors modulate gonadotropin receptor induction in granulosa cell cultures. 
  • High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. 
  • Human chorionic gonadotropin increases the concentration of macrophages in neonatal rat testis. 
  • Hyperglycosylated human chorionic gonadotropin does not increase progesterone production by luteinized granulosa cells. 
  • Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours. 
  • Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination. 
  • In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis. 
  • Inability of gestational hormones to account for the inhibitory effects of pregnancy plasmas on lymphocyte responses in vitro. 
  • Insufficient luteinizing hormone-induced intracellular signaling disrupts ovulation in preovulatory follicles lacking estrogen receptor-{beta}. 
  • Interactions between hormones and growth factors in the regulation of granulosa cell differentiation in vitro. 
  • Kallmann's syndrome: pregnancy achieved through gamete intrafallopian transfer. 
  • Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. 
  • Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. 
  • Luteal phase serum estradiol and progesterone in in vitro fertilization. 
  • Luteal supplementation in in vitro fertilization: more questions than answers. 
  • Luteolytic and abortifacient effects of serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha in early pregnancy. 
  • Microcephaly, hypergonadotropic hypogonadism, short stature, and minor anomalies: a new syndrome. 
  • Monolayer growth and differentiated function of porcine and rat granulosa cells following cryopreservation. 
  • Multiple pregnancies conceived with intrauterine insemination during superovulation: an evaluation of clinical characteristics and monitored parameters of conception cycles. 
  • Natural limits of pregnancy testing in relation to the expected menstrual period. 
  • Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone. 
  • Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin. 
  • Preclinical abortions: incidence and significance in the Norfolk in vitro fertilization program. 
  • Prenatal diagnosis of mosaic trisomy 13: a case report. 
  • Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse. 
  • Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. 
  • Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. 
  • Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2, but only type 2 is regulated by gonadotropin in vitro. 
  • Reappraisal of the role of human chorionic gonadotropin in the diagnosis and treatment of the nonpalpable testis: a 10-year experience. 
  • Regulation of the macrophage population in postnatal rat testis. 
  • Relationship between human chorionic gonadotropin serum levels and the risk of ovarian hyperstimulation syndrome. 
  • Risk of preeclampsia in second-trimester triploid pregnancies. 
  • Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin. 
  • Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia. 
  • Sonographic appearance of the endometrium: the predictive value for the outcome of in-vitro fertilization in stimulated cycles. 
  • Sorbitol dehydrogenase of rat testis: changes of activity during development, after hypophysectomy and following gonadotrophic hormone administration. 
  • Statistical scuds. 
  • Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. 
  • Successful treatment of a cervical pregnancy with a single low dose methotrexate regimen. 
  • Suppression of male-specific cytochrome P450 2c and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl in rat liver is not causally related to changes in serum testosterone. 
  • Synergistic effect of insulin and follicle-stimulating hormone on biochemical and morphological differentiation of porcine granulosa cells in vitro. 
  • Testicular cancer. Clinical practice guidelines in oncology. 
  • Testicular carcinoma. 
  • The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. 
  • The effect of plating density on granulosa cell growth and differentiation in vitro. 
  • The function of the corpus luteum of pregnancy in ovulatory dysfunction and luteal phase deficiency. 
  • The incidence of transient hyperprolactinemia in gonadotropin-stimulated cycles for in vitro fertilization and its effect on pregnancy outcome. 
  • The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. 
  • The prognostic value of serum concentrations of progesterone, estradiol, and luteinizing hormone during superovulation with and without adjunctive leuprolide therapy. 
  • The role of tumor markers in gynecologic oncology. 
  • The value of in vitro fertilization for the treatment of unexplained infertility. 
  • Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program. 
  • Unnecessary mastectomy for gynecomastia in testicular cancer patient. 
  • Use of hMG and/or FSH for multiple follicle development. 
  • Use of human cumulus granulosa cells for in vitro screening of reproductive toxicants. 
  • Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. 
  • hCG, progesterone, alpha-fetoprotein, and estradiol in the identification of ectopic pregnancy. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology